Reaction

Resorption Bone Increased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 809 reports · 26 co-occurring drugs

As of the last recalculation, Resorption Bone Increased appears in 809 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is ALENDRONATE SODIUM (PRR 85.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Alendronate Sodium23885.685.8
Risedronate Sodium4640.340.4
Quinine1133.433.5
Anastrozole4432.632.6
Oseltamivir929.429.4
Rizatriptan Benzoate1128.228.2
Drs. Clotrimazole1227.127.1
Family Wellness Clotrimazole1227.127.1
Clotrimazole Topical1227.127.1
Polatuzumab Vedotin1026.726.7
Cefazolin Sodium1226.026.0
Clotrimazole1225.525.5
Raloxifene Hydrochloride1323.323.3
Mupirocin1223.223.2
Mupirocin Calcium1222.822.8
Sucralfate Oral1222.022.0
Sucralfate Oral Suspension1222.022.0
Carisoprodol1520.620.6
Ribociclib2420.120.1
Ketoconazole Foam1119.419.4
Ketoconazole Cream, 2%1119.319.3
Bendamustine Hcl1118.518.5
Cetirizine Hcl616.917.0
Ifosfamide1113.313.3
Oseltamivir Phosphate1010.710.7
Conjugated Estrogens And Medroxyprogesterone Acetate77.77.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.